Friedrich, M.; Wiedemann, K.; Reiche, K.; Puppel, S.-H.; Pfeifer, G.; Zipfel, I.; Binder, S.; Köhl, U.; Müller, G.A.; Engeland, K.;
et al. The Role of lncRNAs TAPIR-1 and -2 as Diagnostic Markers and Potential Therapeutic Targets in Prostate Cancer. Cancers 2020, 12, 1122.
https://doi.org/10.3390/cancers12051122
AMA Style
Friedrich M, Wiedemann K, Reiche K, Puppel S-H, Pfeifer G, Zipfel I, Binder S, Köhl U, Müller GA, Engeland K,
et al. The Role of lncRNAs TAPIR-1 and -2 as Diagnostic Markers and Potential Therapeutic Targets in Prostate Cancer. Cancers. 2020; 12(5):1122.
https://doi.org/10.3390/cancers12051122
Chicago/Turabian Style
Friedrich, Maik, Karolin Wiedemann, Kristin Reiche, Sven-Holger Puppel, Gabriele Pfeifer, Ivonne Zipfel, Stefanie Binder, Ulrike Köhl, Gerd A. Müller, Kurt Engeland,
and et al. 2020. "The Role of lncRNAs TAPIR-1 and -2 as Diagnostic Markers and Potential Therapeutic Targets in Prostate Cancer" Cancers 12, no. 5: 1122.
https://doi.org/10.3390/cancers12051122
APA Style
Friedrich, M., Wiedemann, K., Reiche, K., Puppel, S.-H., Pfeifer, G., Zipfel, I., Binder, S., Köhl, U., Müller, G. A., Engeland, K., Aigner, A., Füssel, S., Fröhner, M., Peitzsch, C., Dubrovska, A., Rade, M., Christ, S., Schreiber, S., Hackermüller, J.,
... Horn, F.
(2020). The Role of lncRNAs TAPIR-1 and -2 as Diagnostic Markers and Potential Therapeutic Targets in Prostate Cancer. Cancers, 12(5), 1122.
https://doi.org/10.3390/cancers12051122